CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 60 enrolled
Drug / intervention
Wu Ling San +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04144088
NCT04144088Phase 2Completed
CompareCT.gov

Traditional Chinese Medicine in the Treatment of Patients With Hyperuricemia. A Randomized Placebo-Controlled Double-Blinded Clinical Trial.

Chung Shan Medical University·interventional·Posted Oct 30, 2019·Updated Dec 6, 2019

In Brief

A Phase 2 clinical trial evaluating Wu Ling San, Yin-Chen Wu Ling San, and 1 other intervention for Hyperuricemia. Completed, enrolled 60 participants.

Detailed Summary

To testify the efficacy and safety of traditional Chinese formulae, "Wu-Ling San" and "Yin-Chen Wu-Ling San" for patients with hyperuricemia.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHyperuricemia
Countries--
Collaborators--

Timeline

Phase 2CompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedOct 30, 2019
Enrollment StartJun 1, 2006
Primary CompletionJun 30, 2007
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 6.7 years ago

Interventions

Wu Ling Sandrug

assigned to Wu Ling San (n =20) and were instructed to take 4.5 gm 2 times per day of Wu Ling San for a period of 4 weeks.

Yin-Chen Wu Ling Sandrug

assigned to Yin-Chen Wu Ling San (n =20) and were instructed to take 4.5 gm 2 times per day of Yin-Chen Wu Ling San for a period of 4 weeks.

Placebodrug

1/10 Wu Ling San assigned to Placebo (n =20) and were instructed to take 4.5 gm 2 times per day of Placebo for a period of 4 weeks.